Evidence map›Paper›PMID 39170414›Full record

ArticleHeliyon2024

Ertugrul Ozbil, Mehmet Ilktac, Sultan Ogmen, Ovgu Isbilen, Jesus M Duran Ramirez, Jana Gomez, Jennifer N Walker, Ender Volkan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Apoptotic Gene Expression in HepG2 Cells Treated withInternational journal of molecular sciences · 2026
    Article
  2. International journal of molecular sciences · 2026
    Review
  3. Valorization ofPlants (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ertugrul OzbilFaculty of Pharmacy, Eastern Mediterranean University, Famagusta, Northern Cyprus, 99258 via Mersin 10, Turkey.
Mehmet IlktacFaculty of Pharmacy, Eastern Mediterranean University, Famagusta, Northern Cyprus, 99258 via Mersin 10, Turkey.
Sultan OgmenFaculty of Pharmacy, Eastern Mediterranean University, Famagusta, Northern Cyprus, 99258 via Mersin 10, Turkey.
Ovgu IsbilenFaculty of Pharmacy, Department of Pharmaceutical Microbiology, Cyprus International University, Nicosia, Northern Cyprus, 99258 via Mersin 10, Turkey.
Jesus M Duran RamirezDepartment of Microbiology and Molecular Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Texas, USA.
Jana GomezDepartment of Microbiology and Molecular Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Texas, USA.
Jennifer N WalkerDepartment of Microbiology and Molecular Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Texas, USA.
Ender VolkanFaculty of Pharmacy, Department of Pharmaceutical Microbiology, Cyprus International University, Nicosia, Northern Cyprus, 99258 via Mersin 10, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the antibiotic resistance era, utilizing understudied sources for novel antimicrobials or antivirulence agents can provide new advances against antimicrobial resistant pathogens. In this study, we aimed to investigate antibacterial and antibiofilm activities of

Identifiers

PMID39170414
PMCPMC11336879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.